The scientist’s investigation covers issues in Internal medicine, Cancer, Gynecology, Prostate cancer and Cancer screening. His Internal medicine research is multidisciplinary, incorporating elements of Surgery and Oncology. His Cancer study integrates concerns from other disciplines, such as Lung cancer, Lung cancer screening and Randomized controlled trial.
His Randomized controlled trial research integrates issues from Clinical trial and Annual Screening. The concepts of his Gynecology study are interwoven with issues in Ovarian cancer, Disease, Breast cancer, Colorectal cancer and Adjuvant therapy. His Prostate cancer study which covers Prostate that intersects with Carcinoma and Retrospective cohort study.
His primary areas of study are Internal medicine, Cancer, Oncology, Cancer screening and Gynecology. Internal medicine and Surgery are commonly linked in his work. His work in Cancer addresses subjects such as Incidence, which are connected to disciplines such as Epidemiology.
His study brings together the fields of Survival rate and Oncology. His studies in Cancer screening integrate themes in fields like Cumulative incidence, Sigmoidoscopy, Intensive care medicine, Mass screening and Overdiagnosis. His biological study deals with issues like Family medicine, which deal with fields such as Alternative medicine.
Barnett S. Kramer mainly investigates Cancer, Internal medicine, Overdiagnosis, Oncology and Lung cancer. His research integrates issues of Clinical trial and Surgery in his study of Cancer. Barnett S. Kramer has researched Overdiagnosis in several fields, including Epidemiology, Intensive care medicine, Data science and Mass screening.
The Oncology study which covers Prospective cohort study that intersects with Esophageal adenocarcinoma, Aspirin and Survival rate. His work deals with themes such as Prostate cancer and Sigmoidoscopy, which intersect with Cancer screening. Barnett S. Kramer studies Prostate cancer, namely Prostate cancer screening.
Barnett S. Kramer spends much of his time researching Internal medicine, Cancer, Overdiagnosis, Gynecology and Randomized controlled trial. His Internal medicine study frequently intersects with other fields, such as Surgery. Barnett S. Kramer has included themes like Nursing, Oncology, De implementation and Mass screening in his Cancer study.
His Gynecology research incorporates elements of Ovarian cancer screening, Breast cancer, Mammography, Intensive care medicine and Prostate cancer. His work on Randomization as part of general Randomized controlled trial study is frequently connected to Popularity, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. As part of his studies on Cancer screening, he often connects relevant subjects like Prostate.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys.
The New England Journal of Medicine (2009)
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S. Buys;Edward Partridge;Amanda Black;Christine C. Johnson.
JAMA (2011)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys.
Journal of the National Cancer Institute (2012)
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy
Robert E. Schoen;Paul F. Pinsky;Joel L. Weissfeld;Lance A. Yokochi.
The New England Journal of Medicine (2012)
The national lung screening trial: Overview and study design
Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black.
Radiology (2011)
The Role of Increasing Detection in the Rising Incidence of Prostate Cancer
Arnold L. Potosky;Barry A. Miller;Peter C. Albertsen;Barnett S. Kramer.
JAMA (1995)
Ovarian Cancer: Screening, Treatment, and Follow-up
Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld.
JAMA (1995)
Screening by Chest Radiograph and Lung Cancer Mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial
Martin M. Oken;Willam G. Hocking;Paul A. Kvale;Gerald L. Andriole.
JAMA (2011)
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status
John K. Gohagan;Philip C. Prorok;Richard B. Hayes;Barnett S. Kramer.
Controlled Clinical Trials (2000)
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Edward F. Patz;Paul Pinsky;Constantine Gatsonis;Jo Rean D. Sicks.
JAMA Internal Medicine (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Colorado Denver
University of Minnesota
The University of Texas Southwestern Medical Center
Washington University in St. Louis
Huntsman Cancer Institute
University of Toronto
Columbia University
University of Pittsburgh
Eastern Virginia Medical School
University of Minnesota
University of Bologna
University of Bologna
Victoria University
Karlsruhe Institute of Technology
Tokyo Institute of Technology
University of St Andrews
Iowa State University
Queensland University of Technology
National Institutes of Health
University of North Dakota
Norwegian Institute for Air Research
University of Alabama at Birmingham
Brown University
Harvard University
National Institutes of Health
Vanderbilt University